Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Celecor Therapeutics

Clinical trials sponsored by Celecor Therapeutics, explained in plain language.

Not yet finished but already full! 1

Ambulance injection could change heart attack care

Disease control Ongoing

This study tests a single injection of zalunfiban given in the ambulance to people having a severe type of heart attack (STEMI). The goal is to see if the drug improves blood flow and reduces complications like death, stroke, or heart failure within 30 days. About 2,463 participa…

Phase 3 • Sponsor: CeleCor Therapeutics • Aim: Disease control

Last updated Jun 27, 2026 07:55 UTC